NSE: MAXHEALTH · 28 September 2026 · Dated market coverage
- The stock is -2.09% at ₹992.80.
- Likely reason:technical cooling and sector-linked profit-taking
- Approximate traded value is₹20.61 crore.
- It is -18.75% from its 52-week high and +9.94% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Max Healthcare Ins Share Price Falling Today?
Latest NSE EOD report: 2026-09-27. Today’s Volume: 207,607; 5-Day Avg. Volume: 1,387,606; 20-Day Avg. Volume: 1,743,887; Volume vs 20-Day Avg.: 0.12x; Delivery Quantity: 1,090,852; Delivery %: 57.39%; Number of Trades: 39,404.
Max Healthcare Institute Ltd (MAXHEALTH) is trading lower today, down 2.09% at ₹992.80 compared to its previous close of ₹1014.00. The stock opened at ₹1009.70 and has moved within a tight intraday range, hitting a high of ₹1010.80 and a low of ₹992.50. Trading volumes remain subdued, with current volume tracking significantly lower compared to its 5-day and 20-day averages, indicating measured selling pressure rather than heavy liquidation.
The broader market and healthcare segment are also facing downward pressure, though the stock’s pullback aligns with a broader correction in its recent price trajectory. The Nifty index declined by 1.01% while the Nifty Pharma sector benchmark moved down by 0.46%. MAXHEALTH has experienced a sharper near-term pullback, registering a 5-day return loss of 6.95% and a 20-day decline of 4.76%, reflecting persistent short-term profit-taking after lingering near its 52-week highs earlier.
While no single immediate catalyst directly triggered today’s downward drift, the stock’s recent price action coincides with ongoing operational expansions, including the recent inauguration of a new 400-bed tower at Max Smart Super Speciality Hospital, Saket, by Union Home Minister Amit Shah, and the continued funding infusion into Kalinga Hospital Ltd. These developments underscore long-term capacity growth, though immediate sentiment remains influenced by broader market consolidation and technical cooling following prior gains.
low confidence
- Stock down 2.09% amid lower-than-average trading volumes
- Negative 5-day return of 6.95% indicating ongoing short-term consolidation
- Broader market weakness led by a 1.01% drop in the Nifty index
Ownership & Transaction Activity
Plot C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Symbol: MAXHEALTH Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 543220 Sub.: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Dear Sir / Madam, Pursuant to regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, I, Abhay Soi, Promoter of Max Healthcare Institute Limited (“ Company”) hereby declare that I and Mr. Aditya Soi (a member of promoter group) have not made any encumbrance on the shares of Company, directly or indirectly, during the financial year 2024- 25. Kindly take this intimation on your record. Thanking you Abhay Soi CC: Chairman Audit Committee Max Healthcare Institute Limited 401, 4th Floor, Man Excellenza, S. V. Road, Vile Parle (West), Mumbai, Maharashtra – 400 056
Source: NSE corporate filing
- Promoter Abhay Soi and promoter group member Aditya Soi declared no encumbrance on company shares under SEBI Regulation 31(4).
- Institutional shareholding remains robust, with Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) holding significant stakes in the company.
Source: NSE corporate disclosure. Only factual ownership/shareholding details extracted from the filing are shown.
WittyTrades Data Insight
Price Position:The stock is near the lower end of the day’s trading range.
Move From Open:-1.67%.
Intraday Range:1.80% of the previous close.
5-Day Performance:-6.95%; 20-Day Performance:-4.76%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Sustainability of support levels around the ₹990 mark and intraday volume pickup
- Execution progress and patient ramp-up timelines for the newly inaugurated 400-bed Saket tower
- Integration milestones and financial impact of the Kalinga Hospital fund infusion
Catalyst note:No single confirmed fundamental trigger explains today’s price drop; the move reflects routine technical retracement and broader market sentiment.
Frequently Asked Questions
What is the likely reason for today’s move?
The stock’s decline appears driven by mild profit-taking and broader market consolidation following a period of short-term weakness, with no direct negative news event reported today.
Is trading volume elevated?
Today’s volume is 207,607. The latest 20-day average available is 1,743,887, equivalent to about 0.12x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk